| Trial ID: | L6231 |
| Source ID: | NCT06670209
|
| Associated Drug: |
Gzr18 And Metformin
|
| Title: |
A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects
|
| Acronym: |
|
| Status: |
NOT_YET_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: GZR18 and metformin
|
| Outcome Measures: |
Primary: Cmax,ss, 24 hours|AUC0-tau, 24 hours |
|
| Sponsor/Collaborators: |
Sponsor: Gan and Lee Pharmaceuticals, USA
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2024-10-30
|
| Completion Date: |
2025-03-19
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-01
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT06670209
|
